Polymedco nabs investment from RoundTable Healthcare Partners
Category: #health  By Mateen Dalal  Date: 2022-06-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

Polymedco nabs investment from RoundTable Healthcare Partners

RoundTable's deep operating expertise will support Polymedco to increase awareness of CRC screening & cardiac testing

RoundTable Healthcare Partners, an investment firm that focuses on businesses in the medical field, has recently announced the completion of its investment into Polymedco, a leading manufacturer, marketer, and distributor in the clinical laboratory marketplace.

Polymedco’s diagnostic tests are used primarily for CRC (colorectal cancer) screening and diagnosing cardiac conditions like myocardial infarctions.

Based in Cortlandt Manor, NY, the firm's products are sold to payors, hospital systems, distributors, and laboratories across North America.

In the United States, CRC is said to be the second most common cause of cancer deaths, with more than 50,000 deaths yearly (American Cancer Society report).

The rising prevalence of colorectal cancer caused the U.S. Preventative Services Task Force to lower the age recommended for preliminary CRC screening and the non-invasive FIT (fecal immunochemical tests) to 45.

The OC-Auto product line of Polymedco supports high-volume FIT screening of stool for H.B. (hemoglobin) for early identification of blood that may be linked with colorectal cancer.

While commenting on the move, Pete Welsh and Drew Cervasio, the co-founders of Polymedco, said that the firm is extremely proud of the position Polymedco is in currently. RoundTable is the perfect partner for the firm as it moves towards transitioning its business.

The firm's core values align properly with the culture the firm has built. In addition, the deep operating experience of RoundTable will support Polymedco in spreading awareness regarding CRC screening and cardiac testing.

Notably, Polymedco represents the sixth equity investment of RoundTable from the firm's $700 million Fund V.

The senior debt financing was funded by CIT, Capital One, Stifel, CIBC Bank USA, and First Horizon. In addition, RoundTable's captive subordinated debt fund, RoundTable Capital Partners III, offered senior subordinated proceedings.

Source Credit - https://www.prnewswire.com/news-releases/roundtable-healthcare-partners-invests-in-polymedco-alongside-owner-founders-301562038.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Stocks of luxury fashion houses raise in response to China’s reopening
Stocks of luxury fashion houses raise in response to China’s reopening
By Mateen Dalal

Luxury fashion houses dependent on Chinese customers reportedly saw a hike in stocks as China reopens, however, those clients may not necessarily be purchasing the goods elsewhere. In the past, wealthy Chinese customers would frequently buy person...

Microsoft investigates Teams and Outlook outage that left users disrupted
Microsoft investigates Teams and Outlook outage that left users disrupted
By Mateen Dalal

Microsoft, the U.S.-based technology frontrunner, reportedly investigating an outage that prevented thousands of customers from accessing services like Teams and Outlook. Apparently, the tech giant did not disclose the number of users that were im...

DeHaat secures $60 million in funding, tops $700 million valuation
DeHaat secures $60 million in funding, tops $700 million valuation
By Mateen Dalal

Indian agritech firm DeHaat has reportedly raised $60 million in a new funding round as it looks forward to strengthening its footprint in the country and touching break-even profitability in two years. For the unversed, the startup provides a range ...